首页> 外文期刊>Cytometry: The Journal of the Society for Analytical Cytology >Assessing genetic markers of tumour progression in the context of intratumour heterogeneity
【24h】

Assessing genetic markers of tumour progression in the context of intratumour heterogeneity

机译:在肿瘤内异质性的背景下评估肿瘤进展的遗传标记

获取原文
获取原文并翻译 | 示例
           

摘要

This is a report from the Kananaskis working group on quantitative methods in tumour heterogeneity, Tumour progression is currently believed to result from genetic instability and consequent acquisition of new genetic properties in some of the tumour cells, Cross-sectional assessment of genetic markers for human tumours requires quantifiable measures of intratumour heterogeneity for each parameter or characteristic observed; the relevance of heterogeneity to tumour progression can best be ascertained by repeated assessment along a tumour progressional time Line, This paper outlines experimental and analytic considerations that, with repeated use, should lead to a better understanding of tumour heterogeneity, and hence, to improvements in patient diagnosis and therapy, Four general principles were agreed upon at the Symposium: (1) the concept of heterogeneity requires a quantifiable definition so that it can be assessed repeatably; (2) the quantification of heterogeneity is necessary so that testable hypotheses may be formulated and checked to determine the degree of support from observed data; (3) it is necessary to consider (a) what is being measured, (b) what is currently measurable, and (c) what should be measured; and (4) the proposal of working models is a useful step that will assist our understanding of the origins and significance of heterogeneity in tumours. The properties of these models should then be studied so that hypotheses may be refined and validated. (C) 1998 Wiley-Liss, Inc. [References: 28]
机译:这是卡纳纳斯基斯(Kananaskis)工作组关于肿瘤异质性定量方法的报告,目前认为肿瘤的进展是由于遗传不稳定和随后在某些肿瘤细胞中获得新的遗传特性所致,人类肿瘤遗传标志物的横断面评估对于观察到的每个参数或特征,要求量化肿瘤内异质性;异质性与肿瘤进展的相关性最好通过沿着肿瘤进展时间线进行反复评估来确定。本文概述了实验和分析考虑因素,反复使用应有助于更好地理解肿瘤异质性,从而改善肿瘤的异质性。病人的诊断和治疗,在座谈会上达成了四项通用原则:(1)异质性的概念需要量化的定义,以便可以重复评估。 (2)必须对异质性进行量化,以便可以建立和检验可检验的假设,以便从观察到的数据中确定支持程度; (3)有必要考虑(a)正在测量的内容,(b)当前可测量的内容,以及(c)应该测量的内容; (4)工作模型的提出是一个有用的步骤,将有助于我们了解肿瘤异质性的起源和重要性。然后应研究这些模型的性质,以便可以完善和验证假设。 (C)1998 Wiley-Liss,Inc. [参考:28]

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号